Figure2 (Guanfacine 2figure)
Guanfacine Tablet, Extended Release
Product Images NDC 71335-2379
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 71335-2379). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 3 (Guanfacine 3 Figure)
This information provides details on the fold change and 90% confidence interval for the pharmacokinetics (PK) of oral methylphenidate and lisdexamfetamine dimesylate. It includes data on Cmax (maximum concentration) and AUC (area under the curve) for comparison. This data may be useful for assessing the differences in drug exposure and metabolism between the two drugs.*
Figure1 (Guanfacine Figure 1)
Figure 4 (Guanfacine Figure4)
Structure (Guanfacine Str)
Label (Lbl713352379)
This text contains information about a medication called Guanfacine Hydrochloride. Each tablet contains 1 mg of the active ingredient. The tablets are extended-release and should not be crushed, chewed, or broken before swallowing. The medication should be stored at 20° to 25°C. The manufacturer is Bryant Ranch Prepack, Inc. Patients are advised to keep the medication out of reach of children. For more information, visit the provided website link.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
